LC
CDNA icon

Lindbrook Capital’s CareDx CDNA Stock Holding History

Lindbrook Capital’s Portfolio CDNA Stock Details CDNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$4.14K Hold
233
– – ﹤0.01% 2036
2024
Q4 		$4.99K Hold
233
– – ﹤0.01% 1992
2024
Q3 		$7.28K Buy
233
+4
+2% +$100 ﹤0.01% 1836
2024
Q2 		$3.56K Buy
229
+45
+24% +$544 ﹤0.01% 2144
2024
Q1 		$1.95K Hold
184
– – ﹤0.01% 2246
2023
Q4 		$2.21K Buy
+184
New +$1.51K ﹤0.01% 2222
2023
Q3 		– Sell
-58
Closed -$493 – 2702
2023
Q2 		$493 Sell
58
-741
-93% -$6.18K ﹤0.01% 2516
2023
Q1 		$7.3K Buy
799
+778
+3,705% +$9.95K ﹤0.01% 1656
2022
Q4 		$240 Sell
21
-229
-92% -$3.39K ﹤0.01% 2705
2022
Q3 		$4K Buy
250
+29
+13% +$622 ﹤0.01% 1739
2022
Q2 		$5K Hold
221
– – ﹤0.01% 1526
2022
Q1 		$8K Sell
221
-487
-69% -$19K ﹤0.01% 1365
2021
Q4 		$32K Buy
708
+677
+2,184% +$35.3K ﹤0.01% 860
2021
Q3 		$2K Hold
31
– – ﹤0.01% 1509
2021
Q2 		$3K Hold
31
– – ﹤0.01% 1445
2021
Q1 		$2K Buy
+31
New +$2.41K ﹤0.01% 1527

Other funds holding CDNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Lindbrook Capital's CDNA Position: Q1 2025 in Review

Lindbrook Capital held its CareDx (CDNA) position steady in Q1 2025 at 233 shares worth $4.14K. The position accounts for ﹤0.01% of the portfolio, ranked #2036.

Lindbrook Capital first reported a position in CDNA in Q1 2021 and has held it in 16 quarters since. The position peaked at $32K in Q4 2021. 218 funds tracked by Wall St. Rank hold CDNA as of Q1 2025.

  • Lindbrook Capital held 233 shares of CareDx worth $4.14K as of Q1 2025.
  • Lindbrook Capital left its CareDx share count unchanged in Q1 2025.
  • CareDx made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2036 holding.
  • Lindbrook Capital first reported a position in CareDx in Q1 2021 and has held it in 16 quarters since.
  • Lindbrook Capital's CareDx position peaked at $32K in Q4 2021.
  • 218 funds tracked by Wall St. Rank held CareDx as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.